A blood-based metabolite panel for distinguishing ovarian cancer from benign pelvic masses. Irajizad E, Han CY, Celestino J, Wu R, et al. Clin Cancer Res 2022 Aug 29. pii: 708818. doi: 10.1158/1078-0432.CCR-22-1113.

Read + Share

Amedeo Smart

Independent Medical Education

Irajizad E, Han CY, Celestino J, Wu R, et al. A blood-based metabolite panel for distinguishing ovarian cancer from benign pelvic masses. Clin Cancer Res 2022 Aug 29. pii: 708818. doi: 10.1158/1078-0432.CCR-22-1113.
PMID: 36037307